On August 17, 2013, Zhujiang Hotel, Guangzhou. The 6th "CSCO-South" Cancer Biotherapy and Molecular Targeted Therapy Forum was grandly opened under the auspices of Professor Luo Rongcheng, the chairman of the conference, the vice president of Nanfang ...

The 2012 Shenzhen Innovation Committee Innovation Funding Project declared by our company was successfully approved. The funded project of ISKCON is a concrete action to strengthen Shenzhen's technology city and focus on the development of strategic emerging industries. Under the adv...

On August 20, 2013, Dean Cai of Shenzhen Second People's Hospital visited the company and inspected it. The company’s chief scientist Professor Liu Yong and the company’s CEO Mr. Sun personally received them and introduced the company’s technical products and development goals. &...

On August 9, 2012, the company signed an ACTL technology research cooperation agreement with Nanfang Hospital in the No. 1 conference room. This also shows that the company has formally formed a strategic partnership with Nanfang Hospital.          In a warm and...

Congratulations on the successful application of the ACTL technology "targeted anti-prostate cancer cell immunotherapy technology and application" project. With the strong support of the Shenzhen Municipal Government and the care of Nanshan District Committee, Innovation Committee and ...